AU2001249573A1 - Chemokine receptor antagonists - Google Patents

Chemokine receptor antagonists

Info

Publication number
AU2001249573A1
AU2001249573A1 AU2001249573A AU4957301A AU2001249573A1 AU 2001249573 A1 AU2001249573 A1 AU 2001249573A1 AU 2001249573 A AU2001249573 A AU 2001249573A AU 4957301 A AU4957301 A AU 4957301A AU 2001249573 A1 AU2001249573 A1 AU 2001249573A1
Authority
AU
Australia
Prior art keywords
receptor antagonists
chemokine receptor
chemokine
antagonists
receptor
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001249573A
Inventor
Min Chu
Ronald A. Mierzwa
Mahesh G. Patel
Joseph Terracciano
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck Sharp and Dohme Corp
Original Assignee
Schering Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Corp filed Critical Schering Corp
Publication of AU2001249573A1 publication Critical patent/AU2001249573A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/44—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having three double bonds between ring members or between ring members and non-ring members
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/14—Fungi; Culture media therefor
    • C12N1/145—Fungal isolates
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P17/00—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
    • C12P17/10—Nitrogen as only ring hetero atom
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/645—Fungi ; Processes using fungi
AU2001249573A 2000-03-30 2001-03-28 Chemokine receptor antagonists Abandoned AU2001249573A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US19333100P 2000-03-30 2000-03-30
US60193331 2000-03-30
PCT/US2001/010018 WO2001074772A1 (en) 2000-03-30 2001-03-28 Chemokine receptor antagonists

Publications (1)

Publication Number Publication Date
AU2001249573A1 true AU2001249573A1 (en) 2001-10-15

Family

ID=22713200

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001249573A Abandoned AU2001249573A1 (en) 2000-03-30 2001-03-28 Chemokine receptor antagonists

Country Status (9)

Country Link
US (1) US6476062B2 (en)
EP (1) EP1268420A1 (en)
JP (1) JP2003529585A (en)
CN (1) CN1422252A (en)
AU (1) AU2001249573A1 (en)
CA (1) CA2404312A1 (en)
HK (1) HK1047750A1 (en)
MX (1) MXPA02009660A (en)
WO (1) WO2001074772A1 (en)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6962943B2 (en) * 2001-11-21 2005-11-08 Aventis Pharma Deutschland Gmbh Gabusectin derivatives, processes for preparing them and their use
DE10156906A1 (en) * 2001-11-21 2003-05-28 Aventis Pharma Gmbh New 3-(octahydronaphth-1-yl-methylene)-pyrrolidine derivatives, prepared by culturing a microorganism, shows strong antibacterial activity
US8940730B2 (en) 2007-09-18 2015-01-27 The Board Of Trustees Of The Leland Stanford Junior University Methods and compositions of treating a Flaviviridae family viral infection
TW200927102A (en) * 2007-09-18 2009-07-01 Univ Stanford Methods of treating a flaviviridae family viral infection, compositions for treating a flaviviridae family viral infection, and screening assays for identifying compositions for treating a flaviviridae family viral infection
US9101628B2 (en) 2007-09-18 2015-08-11 The Board Of Trustees Of The Leland Stanford Junior University Methods and composition of treating a flaviviridae family viral infection
US9149463B2 (en) * 2007-09-18 2015-10-06 The Board Of Trustees Of The Leland Standford Junior University Methods and compositions of treating a Flaviviridae family viral infection
US8975247B2 (en) 2009-03-18 2015-03-10 The Board Of Trustees Of The Leland Stanford Junion University Methods and compositions of treating a flaviviridae family viral infection
MX343589B (en) 2011-06-19 2016-11-11 Univ New York Leukotoxin e/d as a new anti-inflammatory agent and microbicide.

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL7118100A (en) * 1971-01-07 1972-07-11 Sandoz Ag
US5951974A (en) 1993-11-10 1999-09-14 Enzon, Inc. Interferon polymer conjugates
TW517067B (en) 1996-05-31 2003-01-11 Hoffmann La Roche Interferon conjugates
US5759842A (en) * 1996-10-24 1998-06-02 Merck & Co., Inc. In vitro HIV integrase inhibitors
US6124327A (en) * 1997-07-29 2000-09-26 Merck & Co., Inc. HIV integrase inhibitors

Also Published As

Publication number Publication date
US20020128307A1 (en) 2002-09-12
CN1422252A (en) 2003-06-04
WO2001074772A1 (en) 2001-10-11
JP2003529585A (en) 2003-10-07
EP1268420A1 (en) 2003-01-02
MXPA02009660A (en) 2003-03-10
CA2404312A1 (en) 2001-10-11
US6476062B2 (en) 2002-11-05
HK1047750A1 (en) 2003-03-07

Similar Documents

Publication Publication Date Title
AU5274499A (en) Therapeutic chemokine receptor antagonists
AU2001250205A1 (en) Prostaglandin d2 receptor antagonists
IL153308A0 (en) Thrombin receptor antagonists
AU2001255798A1 (en) Glucagon antagonists
AU2002235224A1 (en) Muscarinic antagonists
AU2001273032A1 (en) Cytokine receptor zcytor17
AU2001264657A1 (en) Crf receptor antagonists
AU2001290772A1 (en) Alpha v integrin receptor antagonists
AU2441801A (en) Urotensin-ii receptor antagonists
AU2001286409A1 (en) N-methyl-d-aspartate receptor antagonists
AU2001240021A1 (en) Diazafluorenone il-8 receptor antagonists
AU2001245724A1 (en) Il-8 receptor antagonists
EP1296958A4 (en) Iminopyrimidine nmda nr2b receptor antagonists
MXPA01012165A (en) Chemokine receptor ccr3 antagonists.
AU2002226048A1 (en) Urotensin-ii receptor antagonists
AU2002216079A1 (en) Bombesin receptor antagonists
AU2001243351A1 (en) Il-8 receptor antagonists
AU2002239506A1 (en) Urotensin-ii receptor antagonists
AU2001249573A1 (en) Chemokine receptor antagonists
AU2001263288A1 (en) Crf receptor antagonists
AU2002217095A1 (en) Bombesin receptor antagonists
AU2001253172A1 (en) Il-8 receptor antagonists
AU2001241896A1 (en) Il-8 receptor antagonists
AU2574801A (en) Selective iGLUR5 receptor antagonists
AU2001245605A1 (en) Il-8 receptor antagonists